Reading the tape
NYSE: NVST
Envista Holdings Corp
Healthcare · Medical - Equipment & Services
Market Cap
$4.27B
52w High
$30.42
52w Low
$16.32
P/E
91.61
Volume
1.75M
Outstanding Shares
162.98M
Price vs Fundamentals
Why The Stock Is Moving
Mixed / unclearLow confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 54.74%Revenue (TTM): 8.32%FCF (TTM): -23.89%P/FCF: 50th pct
What changed
The stock rose 54.74% over the last year. Revenue grew 8.32% over the trailing twelve months. Operating margin moved from -41.35% to 8.47%. Free cash flow declined 23.89% over the trailing twelve months.
What the market seems to be pricing
The stock has moved higher against modestly improving underlying metrics. The operating data does not yet tell a clear story — the move may reflect sentiment, sector rotation, or macro factors rather than company-specific earnings power.
What would invalidate this read
Operating margin currently stands at 8.47%. A decisive move in revenue — currently up 8.32% — would be the clearest signal to resolve the ambiguity.
Company profile
Envista Holdings Corp. manufactures and markets dental products for diagnosing, treating and preventing dental conditions.
CEOPaul A. Keel
SectorHealthcare
IndustryMedical - Equipment & Services
Employees12,300
IPO dateSep 18, 2019
Valuation
Forward P/E—
EV/EBITDA12.13
Enterprise value$4.14B
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth14.96%
Gross margin54.95%▼0.74%vs FY2024
Operating margin8.47%▲120.07%vs FY2024
ROE1.51%▲103.97%vs FY2024
Analyst consensus
RatingHold
Target price$27.00▲3.09%
7
Buy
11
Hold
1
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 6, 2026
Q2 FY26 · EPS est $0.31 · Revenue est $680.07M
View